Sorry, this entry is only available in Ukrainian.
Втрата патентного захисту семаглутиду у 2026 році: революція в лікуванні ожиріння
Вас может заинтересовать:
WEB only
PJSC “FITOFARM” continues to resume production of its drugs. The company concluded an agreement on contract production with a new partner – PE “KILAFF”. The “KILAFF” company is a reliable…
WEB only
The Syntegon Group, a provider of processing and packaging technology, appointed Torsten Türling as new Chief Executive Officer (CEO). He succeeds Dr. Michael Grosse, who will leave the company by…
